搜索此博客

2019年7月8日星期一

Revefenacin 864750-70-9, CAS 864750-70-9 Free sample

Revefenacin 864750-70-9, CAS 864750-70-9 Free sample
Revefenacin 864750-70-9, CAS 864750-70-9, EE 99.9%, Revefenacin 864750-70-9, CAS 864750-70-9,HPLC more than 99.5%, Impurity less than 0.1%, Water less than 0.1%, stock keep 10-50kg.
Revefenacin 864750-70-9, CAS 864750-70-9 stable novel crystalline or amorphous form both we have, Revefenacin 864750-70-9, CAS 864750-70-9no any IP problem. Revefenacin 864750-70-9, CAS 864750-70-9 DMF filling, free sample of Revefenacin 864750-70-9, CAS 864750-70-9.

EOS Med Chem have already carried out Revefenacin 864750-70-9, CAS 864750-70-9 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Revefenacin 864750-70-9, CAS 864750-70-9 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is Revefenacin 864750-70-9, CAS 864750-70-9 Intermeidates list, most from GMP plant:

Revefenacin 864750-70-9, CAS 864750-70-9 Intermediate,  17337-13-2, stock 5.9kg, assay 98.9%, White powder.
Revefenacin 864750-70-9, CAS 864750-70-9 Intermediate,  171722-92-2, stock 9.9kg, assay 99%, White powder.
Revefenacin 864750-70-9, CAS 864750-70-9 Intermediate,  166947-11-1, stock 2.4kg, assay 98.9%, White powder.
Revefenacin 864750-70-9, CAS 864750-70-9 Intermediate,  864686-28-2, stock 1.1kg, assay 98.1%, White powder.
Revefenacin 864750-70-9, CAS 864750-70-9 Intermediate,  743460-48-2, stock 6.3kg, assay 98.2%, White powder.
Revefenacin 864750-70-9, CAS 864750-70-9 Intermediate,  864760-28-1, stock 3.7kg, assay 98.2%, White powder.
Revefenacin 864750-70-9, CAS 864750-70-9 Intermediate,  101-98-4, stock 1.6kg, assay 98.8%, White powder.

Revefenacin 864750-70-9, CAS 864750-70-9 HNMR, MASS, COA, MSDS we have.

Revefenacin 864750-70-9, CAS 864750-70-9, free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com